Jarari, L.

neuropathy mirna patient expression donor-derived bm mscs hsa-mir myeloma bortezomib-induced cluster grade bortezomib 0.001 table fak þ lscs treatment figure analysis cycle *** donor-derived mm patients development signi myeloma plasma cells cancer study factor bm mscs intron vincristine-induced late-onset coding early-onset leukemia protein non-synonymou signi ficant snps mirna expression late-onset bortezomib-induced aml-derived fak activity induction phenotype 2–4 apoptosi pathway target ficant value fication toulouse trial activity microrna niche vincristine report survival correlation mann –whitney u-test upregulated fak þ car phenotype 0.1 system variation early-onset bortezomib-induced research gene expression mirna -21 upregulation sample identi -21 level letter testing errors 2 weeks editor france